Chorulon 1500 IU Powder and solvent for solution for injection

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Chorionic gonadotrophin

Available from:

Intervet Ireland Limited

ATC code:

QG03GA01

INN (International Name):

Chorionic gonadotrophin

Dosage:

1500 international unit(s)

Pharmaceutical form:

Powder and solvent for solution for injection

Prescription type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutic group:

Cattle, Dogs, Horses

Therapeutic area:

chorionic gonadotrophin

Therapeutic indications:

Hormone

Authorization status:

Authorised

Authorization date:

1989-10-01

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Chorulon 1500 IU Powder and solvent for solution for injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each powder vial contains:
ACTIVE SUBSTANCE
human Chorionic Gonadotrophin
1500 IU
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Powder and solvent for solution for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, horse, dog
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Therapeutic indications:
improvement
of conception rate (cow),
induction of ovulation (mare,
bitch),
cystic ovaries
with irregular oestrus cycle,
nymphomania,
or absence of oestrus (cow),
anoestrus (mare,
bitch),
delayed ovulation /
prolonged oestrus (bitch), cryptorchidism (male dog), deficiency in
libido (male dog).
4.3 CONTRAINDICATIONS
Do not use in known cases of hypersensitivity to the active
ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
As with all protein preparations, anaphylactic reactions might occur
very seldomly.
Adrenaline (1 : 1000) can be injected i.v. or i.m. when such symptoms
appear.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL
PRODUCT TO ANIMALS
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_9_
_/_
_0_
_8_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_2_
_2_
_1_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.6 ADVERS